Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors

BACKGROUND: Approximately 20% of cancer survivors treated with chemotherapy experience worsening heart failure (HF) symptoms post-cancer treatment. While research has predominantly investigated the role of cardiotoxic treatments, much less attention has focused on other risk factors, such as adiposi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiooncology
Autors principals: Reding, Kerryn W., O’Connell, Nathaniel S., D’Agostino, Ralph B., Hundley, William, Lucas, Alexander R., Ladd, Amy C., Jordan, Jennifer H., Heiston, Emily M., Ge, Yaorong, Hundley, W. Gregory
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105949/
https://ncbi.nlm.nih.gov/pubmed/33964981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-021-00102-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars